West Pharmaceutical Services, Inc. (LON:0ADY)
London flag London · Delayed Price · Currency is GBP · Price in USD
238.10
-18.08 (-7.06%)
At close: Jan 28, 2026

LON:0ADY Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,86614,70718,94920,45414,46125,659
Market Cap Growth
-35.64%-22.38%-7.36%41.44%-43.64%67.27%
Enterprise Value
12,52114,46518,80319,98914,10525,384
Last Close Price
172.87206.09----
PE Ratio
35.0740.0948.1543.9129.7452.50
PS Ratio
5.636.448.208.836.0412.27
PB Ratio
5.456.238.849.046.4914.88
P/TBV Ratio
5.666.479.259.456.8115.78
P/FCF Ratio
36.9342.2285.8362.8639.65105.09
P/OCF Ratio
22.9426.2336.3133.5524.0759.49
EV/Sales Ratio
5.556.338.148.635.8912.14
EV/EBITDA Ratio
20.3124.8331.4330.1919.2238.58
EV/EBIT Ratio
27.2031.7839.6636.0522.2544.72
EV/FCF Ratio
35.9441.5285.1761.4338.68103.97
Debt / Equity Ratio
0.100.100.110.110.120.14
Debt / EBITDA Ratio
0.390.390.390.350.350.36
Debt / FCF Ratio
0.690.691.110.750.720.98
Net Debt / Equity Ratio
-0.15-0.15-0.07-0.19-0.21-0.19
Net Debt / EBITDA Ratio
-0.60-0.60-0.24-0.65-0.65-0.49
Net Debt / FCF Ratio
-1.00-1.00-0.65-1.31-1.31-1.32
Asset Turnover
0.780.780.770.790.830.93
Inventory Turnover
4.804.804.674.284.414.73
Quick Ratio
2.092.091.932.072.732.13
Current Ratio
3.023.022.802.883.702.93
Return on Equity (ROE)
16.86%16.86%17.71%21.32%23.34%31.59%
Return on Assets (ROA)
9.68%9.68%9.93%11.86%13.78%15.73%
Return on Invested Capital (ROIC)
18.10%18.88%20.14%26.35%31.89%38.14%
Return on Capital Employed (ROCE)
16.90%16.90%19.20%22.40%24.70%28.30%
Earnings Yield
2.85%2.49%2.08%2.28%3.36%1.91%
FCF Yield
2.71%2.37%1.17%1.59%2.52%0.95%
Dividend Yield
0.27%0.31%----
Payout Ratio
12.40%12.40%12.00%9.61%9.23%7.72%
Buyback Yield / Dilution
1.36%1.36%2.13%0.66%0.66%-0.66%
Total Shareholder Return
1.63%1.66%2.13%0.66%0.66%-0.66%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.